In clear cell renal cell carcinoma (ccRCC), FTO inhibits the presence and expression of von Hippel-Lindau (VHL) tumor suppressors, which limit tumor progression and progression by inhibiting FTO. This evidence concerns the gene VHL and neoplasm.